Novartis is reimagining medicine to improve and extend people?s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world's top companies investing in research and development. Novartis products reach nearly 800 million people globally and we are finding innovative ways to expand access to our latest treatments. About 110,000 people of more than 140 nationalities work at Novartis around the world. Find out more at https://www.novartis.com
In early 2020, Novartis Vietnam Ltd. became the first multinational pharmaceutical company to successfully transform into a foreign-invested enterprise and fully operationalize its import activities. Through long-term commitments, Novartis is supporting the domestic healthcare system and contributing to the socio-economic development of the country. Novartis is a leader in innovative medicines across many therapeutic areas: Oncology, Cardiovascular (hypertension, heart failure, diabetes), Respiratory (Asthma, COPD); Ophthalmology; Pain relief; Neuroscience, Dermatology and Immunology, Cell and Gene therapy... We are also a leader in high quality generics and biosimilars through our Sandoz unit, and one of the largest investors in clinical trials in Vietnam.